Dr. David Diemert spoke with WTOP and Healio to discuss The NIH enrolling participants in a clinical trial to investigate the efficacy of fractional doses of monkeypox vaccine, and another trial evaluating the antiviral tecovirimat in adults and children with monkeypox.
David Diemert Discusses the MonkeyPox Clinical Trial at GW
Latest News
The George Washington University (GW), Medical Faculty Associates, Inc. (MFA) and Universal Health Services, Inc. (UHS) today announced a definitive agreement on a sustainable framework for the continued provision of patient care at GW Hospital, Cedar Hill Regional Medical Center and affiliated…
Andrew W. Artenstein, MD, MBA, joined the George Washington University on March 2 as the interim vice president for health affairs and dean of the School of Medicine and Health Sciences, bringing a deep background in infectious diseases and academic medicine. Artenstein discussed his first weeks on…
The George Washington University School of Medicine and Health Sciences Research Showcase featured research abstracts, offering a platform for medical students, residents, PhD candidates, and health sciences scholars to share their work in basic sciences, clinical and translational research, public…